Ceramides in Parkinson’s Disease: From Recent Evidence to New Hypotheses
FRONT NEUROSCI-SWITZ

Plotegher N, Bubacco L, Greggio E, Civiero L

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils.
NEUROBIOL DIS

Russo I, Kaganovich A, Ding J, Landeck N, Mamais A, Varanita T, Biosa A, Tessari I, Bubacco L, Greggio E, Cookson MR

Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View
MOL NEUROBIOL

Biosa A, Outeiro TF, Bubacco L, Bisaglia M

Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson's Disease.
ACS CHEM NEUROSCI

Biosa A, Arduini I, Soriano ME, Giorgio V, Bernardi P, Bisaglia M, Bubacco L

Impacts of increased α-synuclein on clathrin-mediated endocytosis at synapses: implications for neurodegenerative diseases
NEURAL REGEN RES

Medeiros AT, Bubacco L, Morgan JR.